Caudatin blocks the proliferation, stemness and glycolysis of non-small cell lung cancer cells through the Raf/MEK/ERK pathway
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutical Biology"
DOI: 10.1080/13880209.2022.2050768
Abstract: Abstract Context The antitumor effects of caudatin have been explored in multiple cancers, but the research on lung cancer has not been fully understood. Objective We explored the effects of caudatin on non-small cell lung… read more here.
Keywords: lung cancer; raf mek; stemness glycolysis; caudatin ... See more keywords